NCT05309291View on ClinicalTrials.gov

Theranova Randomized, Controlled, Trial (RCT) in China

NACompletedINTERVENTIONAL
Enrollment

323

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

July 6, 2023

Study Completion Date

July 6, 2023

Conditions
Chronic Kidney FailureAcute Kidney Failure
Interventions
DEVICE

Theranova 400 Dialyzer

Dialysis performed in HD mode.

DEVICE

FX 800 Dialyzer

Dialysis performed in HDF mode.

Trial Locations (10)

100013

Investigational Site, Beijing

100034

Investigational Site, Beijing

116001

Investigational Site, Dalian

116011

Investigational Site, Dalian

200011

Investigational Site, Shanghai

200127

Investigational Site, Shanghai

210002

Investigational Site, Nanjing

215006

Investigational Site, Suzhou

310014

Investigational Site, Hangzhou

518020

Investigational Site, Shenzhen

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Vantive Health LLC

INDUSTRY